Pitfalls of cell-systematic evolution of ligands by exponential enrichment (SELEX): Existing dead cells during in vitro selection anticipate the enrichment of specific aptamers

Oligonucleotides

Volumn 20, Issue 6, 2010, Pages 317-323

  Avci Adali, Meltem ^a   Metzger, Markus ^a   Perle, Nadja ^a   Ziemer, Gerhard ^a   Wendel, Hans P ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; LIGAND; SINGLE STRANDED DNA BINDING PROTEIN;

ARTICLE; CELL DEATH; CELL FRACTIONATION; CELL POPULATION; CELL SELECTION; CELL STRAIN HEK293; CELL SUSPENSION; CELL VIABILITY; COMBINATORIAL CHEMISTRY; EMBRYO; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; STAINING;

APTAMERS, NUCLEOTIDE; BASE SEQUENCE; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA PRIMERS; FLOW CYTOMETRY; HUMANS; HYDROGEN PEROXIDE; LIGANDS; SELEX APTAMER TECHNIQUE;

EID: 78650400776     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2010.0253     Document Type: Article

References (32)

1. AVCI-ADALI, M., ZIEMER, G., and WENDEL, H.P. (2010). Induction of EPC homing on biofunctionalized vascular grafts for rapid in vivo self-endothelialization-a review of current strategies. Biotechnol. Adv. 28, 119-129.
2. BING, T., LIU, X., CHENG, X., CAO, Z., and SHANGGUAN, D. (2010). Bifunctional combined aptamer for simultaneous separation and detection of thrombin. Biosens. Bioelectron. 25, 1487-1492.
3. BLANK, M., and BLIND, M. (2005). Aptamers as tools for target validation. Curr. Opin. Chem. Biol. 9, 336-342.
4. BOCK, L.C., GRIFFIN, L.C., LATHAM, J.A., VERMAAS, E.H., and TOOLE, J.J. (1992). Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 355, 564-566.
5. CERCHIA, L., DUCONGE, F., PESTOURIE, C., BOULAY, J., AISSOUNI, Y., GOMBERT, K., TAVITIAN, B., DE FRANCISCIS, V., and LIBRI, D. (2005). Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase. PLoS Biol. 3, e123.
6. COSMI, B. (2009). ARC-1779, a PEGylated aptamer antagonist of von Willebrand factor for potential use as an anticoagulant or antithrombotic agent. Curr. Opin. Mol. Ther. 11, 322-328.
7. ELDRIDGE, B., COOLEY, R.N., ODEGRIP, R., MCGREGOR, D.P., FITZGERALD, K.J., and ULLMAN, C.G. (2009). An in vitro selection strategy for conferring protease resistance to ligand binding peptides. Protein Eng. Des. Sel. 22, 691-698.
8. ELLINGTON, A.D., and SZOSTAK, J.W. (1990). In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818-822.
9. FAROKHZAD, O.C., CHENG, J., TEPLY, B.A., SHERIFI, I., JON, S., KANTOFF, P.W., RICHIE, J.P., and LANGER, R. (2006). Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl. Acad. Sci. U. S. A. 103, 6315-6320.
10. GUO, K.T., PAUL, A., SCHICHOR, C., ZIEMER, G., and WENDEL, H.P. (2008). CELL-SELEX: novel perspectives of aptamer-based therapeutics. Int. J. Mol. Sci. 9, 668-678.
11. GUO, K.T., SCHAFER, R., PAUL, A., GERBER, A., ZIEMER, G., and WENDEL, H.P. (2006). A new technique for the isolation and surface immobilization of mesenchymal stem cells from whole bone marrow using high-specific DNA aptamers. Stem Cells 24, 2220-2231.
12. HICKE, B.J., MARION, C., CHANG, Y.F., GOULD, T., LY-NOTT, C.K., PARMA, D., SCHMIDT, P.G., and WARREN, S. (2001). Tenascin-C aptamers are generated using tumor cells and purified protein. J. Biol. Chem. 276, 48644-48654.
13. HOFFMANN, J., PAUL, A., HARWARDT, M., GROLL, J., RE-ESWINKEL, T., KLEE, D., MOELLER, M., FISCHER, H., WALKER, T., GREINER, T., ZIEMER, G., and WENDEL, H.P. (2008). Immobilized DNA aptamers used as potent attractors for porcine endothelial precursor cells. J. Biomed. Mater. Res. A 84, 614-621.
14. HUANG, Y.F., SHANGGUAN, D., LIU, H., PHILLIPS, J.A., ZHANG, X., CHEN, Y., and TAN, W. (2009). Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells. Chembiochem. 10, 862-868.
15. KHATI, M. (2010). The future of aptamers in medicine. J. Clin. Pathol. 63, 480-487.
16. LEE, H.S., KIM, K.S., KIM, C.J., HAHN, S.K., and JO, M.H. (2009). Electrical detection of VEGFs for cancer diagnoses using anti-vascular endotherial growth factor aptamer-modified Si nanowire FETs. Biosens. Bioelectron. 24, 1801-1805.
17. LIU, G., MAO, X., PHILLIPS, J.A., XU, H., TAN, W., and ZENG, L. (2009). Aptamer-nanoparticle strip biosensor for sensitive detection of cancer cells. Anal. Chem. 81, 10013-10018.
18. MALLIKARATCHY, P., TANG, Z., KWAME, S., MENG, L., SHANGGUAN, D., and TAN, W. (2007). Aptamer directly evolved from live cells recognizes membrane bound immunoglobin heavy mu chain in Burkitt's lymphoma cells. Mol.Cell Proteomics 6, 2230-2238.
19. MAYER, G. (2009). The chemical biology of aptamers. Angew. Chem. Int. Ed. Engl. 48, 2672-2689.
20. PAI, S.S., and ELLINGTON, A.D. (2009). Using RNA aptamers and the proximity ligation assay for the detection of cell surface antigens. Methods Mol. Biol. 504, 385-398.
21. PAN, Y., GUO, M., NIE, Z., HUANG, Y., PAN, C., ZENG, K., ZHANG, Y., and YAO, S. (2010). Selective collection and detection of leukemia cells on a magnet-quartz crystal micro-balance system using aptamer-conjugated magnetic beads. Biosens. Bioelectron. 25, 1609-1614.
22. PHILLIPS, J.A., XU, Y., XIA, Z., FAN, Z.H., and TAN, W. (2009). Enrichment of cancer cells using aptamers immobilized on a microfluidic channel. Anal. Chem. 81, 1033-1039.
23. PYLE, A.M. (2002). Metal ions in the structure and function of RNA. J. Biol. Inorg. Chem. 7, 679-690.
24. RADDATZ, M.S., DOLF, A., ENDL, E., KNOLLE, P., FAMU-LOK, M., and MAYER, G. (2008). Enrichment of cell-targeting and population-specific aptamers by fluorescence-activated cell sorting. Angew. Chem. Int. Ed. Engl. 47, 5190-5193.
25. ROBERTSON, D.L., and JOYCE, G.F. (1990). Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA. Nature 344, 467-468.
26. SCHAFER, R., WISKIRCHEN, J., GUO, K., NEUMANN, B., KEHLBACH, R., PINTASKE, J., VOTH, V., WALKER, T., SCHEULE, A.M., GREINER, T.O., HERMANUTZ-KLEIN, U., CLAUSSEN, C.D., NORTHOFF, H., ZIEMER, G., and WEN-DEL, H.P. (2007). Aptamer-based isolation and subsequent imaging of mesenchymal stem cells in ischemic myocard by magnetic resonance imaging. Rofo 179, 1009-1015.
27. SHANGGUAN, D., CAO, Z., MENG, L., MALLIKARATCHY, P., SEFAH, K., WANG, H., LI, Y., and TAN, W. (2008a). Cell-specific aptamer probes for membrane protein elucidation in cancer cells. J. Proteome Res. 7, 2133-2139.
28. SHANGGUAN, D., LI, Y., TANG, Z., CAO, Z.C., CHEN, H.W., MALLIKARATCHY, P., SEFAH, K., YANG, C.J., and TAN, W. (2006). Aptamers evolved from live cells as effective molecular probes for cancer study. Proc. Natl. Acad. Sci. U. S. A. 103, 11838-11843.
29. SHANGGUAN, D., MENG, L., CAO, Z.C., XIAO, Z., FANG, X., LI, Y., CARDONA, D., WITEK, R.P., LIU, C., and TAN, W. (2008b). Identification of liver cancer-specific aptamers using whole live cells. Anal. Chem. 80, 721-728.
30. TAIMOR, G., LORENZ, H., HOFSTAETTER, B., SCHLUTER, K.D., and PIPER, H.M. (1999). Induction of necrosis but not apoptosis after anoxia and reoxygenation in isolated adult cardiomyocytes of rat. Cardiovasc. Res. 41, 147-156.
31. TANG, Z., SHANGGUAN, D., WANG, K., SHI, H., SEFAH, K., MALLIKRATCHY, P., CHEN, H.W., LI, Y., and TAN, W. (2007). Selection of aptamers for molecular recognition and characterization of cancer cells. Anal. Chem. 79, 4900-4907.
32. ZHAO, Q., MATSON, S., HERRERA, C.J., FISHER, E., YU, H., and KRIEG, A.M. (1993). Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucle-otides. Antisense Res. Dev. 3, 53-66.